nach oben

Surgical Endoscopy

Erschienen in:

24.09.2018 | 2018 SAGES Oral

Long-term impact of bariatric surgery in diabetic nephropathy

verfasst von: LeAnne Young, Zubaidah Nor Hanipah, Stacy A. Brethauer, Philip R. Schauer, Ali Aminian

Erschienen in: Surgical Endoscopy | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Bariatric surgery has been shown to improve and resolve diabetes. However, limited literature about its impact on end-organ complications of diabetes is available. The aim of this study was to examine the long-term effect of bariatric surgery on albuminuria.

Methods

We studied 101 patients with pre-operative diabetes and albuminuria [defined as urine albumin:creatinine ratio (uACR) > 30 mg/g] who underwent bariatric surgery at an academic center from 2005 to 2014.

Results

Fifty-seven patients (56%) were female with a mean age of 53 (± 11) years. The mean pre-operative BMI and glycated hemoglobin (HbA1c) were 43.1 (± 7.6) kg/m² and 8.4 (± 1.8)%, respectively. The median pre-operative uACR was 80.0 (45.0–231.0) mg/g. Bariatric procedures included Roux-en-Y gastric bypass (n = 75, 74%) and sleeve gastrectomy (n = 26, 26%). The mean follow-up period was 61 (± 29) months. At last follow-up, the mean BMI was 33.8 (± 8.3) kg/m². The overall glycemic control improved after bariatric surgery. At last follow-up, 73% had good glycemic control (HbA1c < 7%) and 27% met diabetes remission criteria. The mean HbA1c at last follow-up was 6.7 (± 1.0)% and the median uACR was 30 (IQR 7–94) mg/g. Albuminuria improved in 77% and resolved in 51% of patients at long-term.

Conclusions

Bariatric surgery has a significantly positive impact on albuminuria in patients with obesity and type 2 diabetes. Our data showed almost an 80% improvement in albuminuria at the short- and long-term period after bariatric surgery.

Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving H-H, Steffes MW, American Diabetes Association (2004) Nephropathy in diabetes. Diabetes Care 27(Suppl 1):S79–S83. https://doi.org/10.2337/DIACARE.27.2007.S79 CrossRefPubMed

Postma MJ, de Zeeuw D (2009) The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus. Nephrol Dial Transplant 24:2975–2983. https://doi.org/10.1093/ndt/gfp352 CrossRefPubMed

Damien P, Lanham HJ, Parthasarathy M, Shah NL (2016) Assessing key cost drivers associated with caring for chronic kidney disease patients. BMC Health Serv Res 16:690. https://doi.org/10.1186/s12913-016-1922-4 CrossRefPubMedPubMedCentral

Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders H-J (2017) Chronic kidney disease. Nat Rev Dis Prim 3:17088. https://doi.org/10.1038/nrdp.2017.88 CrossRefPubMed

Burrows NR, Hora I, Geiss LS, Gregg EW, Albright A (2017) Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes—United States and Puerto Rico, 2000–2014. MMWR Morb Mortal Wkly Rep 66:1165–1170. https://doi.org/10.15585/mmwr.mm6643a2 CrossRefPubMedPubMedCentral

González-Muniesa P, Mártinez-González M-A, Hu FB, Després J-P, Matsuzawa Y, Loos RJF, Moreno LA, Bray GA, Martinez JA (2017) Obesity. Nat Rev Dis Prim 3:17034. https://doi.org/10.1038/nrdp.2017.34 CrossRefPubMed

Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ (2008) Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 73:19–33. https://doi.org/10.1038/sj.ki.5002586 CrossRefPubMed

Hsu C, McCulloch CE, Iribarren C, Darbinian J, Go AS (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144:21. https://doi.org/10.7326/0003-4819-144-1-200601030-00006 CrossRefPubMed

Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G (2017) A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int 91:1224–1235. https://doi.org/10.1016/j.kint.2016.12.013 CrossRefPubMed

10.

Bayliss G, Weinrauch LA, D’Elia JA (2012) Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy. Curr Diab Rep 12:440–446. https://doi.org/10.1007/s11892-012-0288-1 CrossRefPubMed

11.

Rossi M, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, Giorda C, Pomili B, Valentini U, Vespasiani G, De Cosmo S (2010) Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND study. Nutr Metab Cardiovasc Dis. https://doi.org/10.1016/j.numecd.2009.02.013 CrossRefPubMed

12.

Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery. JAMA 292:1724. https://doi.org/10.1001/jama.292.14.1724 CrossRefPubMed

13.

Carlsson LMS, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, Jacobson P, Lönroth H, Maglio C, Näslund I, Pirazzi C, Romeo S, Sjöholm K, Sjöström E, Wedel H, Svensson P-A, Sjöström L (2012) Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 367:695–704. https://doi.org/10.1056/NEJMoa1112082 CrossRefPubMed

14.

Maciejewski ML, Arterburn DE, Van Scoyoc L, Smith VA, Yancy WS, Weidenbacher HJ, Livingston EH, Olsen MK, Olsen MK (2016) Bariatric surgery and long-term durability of weight loss. JAMA Surg 151:1046–1055. https://doi.org/10.1001/jamasurg.2016.2317 CrossRefPubMedPubMedCentral

15.

Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR (2017) Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med 376:641–651. https://doi.org/10.1056/NEJMoa1600869 CrossRefPubMedPubMedCentral

16.

Aminian A (2018) Sleeve gastrectomy: metabolic surgical procedure of choice? Trends Endocrinol Metab 29:531–534CrossRefPubMed

17.

Aminian A, Brethauer SA, Andalib A, Nowacki AS, Jimenez A, Corcelles R, Hanipah ZN, Punchai S, Bhatt DL, Kashyap SR, Burguera B, Lacy AM, Vidal J, Schauer PR (2017) Individualized metabolic surgery score. Ann Surg 266:650–657. https://doi.org/10.1097/SLA.0000000000002407 CrossRefPubMed

18.

Ardestani A, Rhoads D, Tavakkoli A (2015) Insulin cessation and diabetes remission after bariatric surgery in adults with insulin-treated type 2 diabetes. Diabetes Care 38:dc141751. https://doi.org/10.2337/dc14-1751 CrossRef

19.

Aminian A, Daigle CR, Romero-Talamás H, Kashyap SR, Kirwan JP, Brethauer SA, Schauer PR (2014) Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis 10:576–582. https://doi.org/10.1016/j.soard.2014.01.025 CrossRefPubMed

20.

Wong MG, Perkovic V, Chalmers J, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, MacMahon S, Mancia G, Marre M, Matthews D, Neal B, Poulter N, Rodgers A, Williams B, Zoungas S, ADVANCE-ON Collaborative Group (2016) Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON. Diabetes Care 39:694–700. https://doi.org/10.2337/dc15-2322 CrossRefPubMed

21.

Resnick HE, Foster GL, Bardsley J, Ratner RE (2006) Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999–2002: the National Health and Nutrition Examination Survey. Diabetes Care 29:531–537. https://doi.org/10.2337/DIACARE.29.03.06.DC05-1254 CrossRefPubMed

22.

American Diabetes Association (2018) Standards of medical care in diabetes—2018. Diabetes Care 41:S3. https://doi.org/10.2337/dc18-Sppc01 CrossRef

23.

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KGMM, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE, Delegates of the 2nd Diabetes Surgery Summit (2016) Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 39:861–877. https://doi.org/10.2337/dc16-0236 CrossRefPubMed

24.

Morales E, Praga M (2012) The effect of weight loss in obesity and chronic kidney disease. Curr Hypertens Rep 14:170–176. https://doi.org/10.1007/s11906-012-0247-x CrossRefPubMed

25.

Heneghan HM, Cetin D, Navaneethan SD, Orzech N, Brethauer SA, Schauer PR (2013) Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis 9:7–14. https://doi.org/10.1016/j.soard.2012.08.016 CrossRefPubMed

26.

Upala S, Wijarnpreecha K, Congrete S, Rattanawong P, Sanguankeo A (2016) Bariatric surgery reduces urinary albumin excretion in diabetic nephropathy: a systematic review and meta-analysis. Surg Obes Relat Dis 12:1037–1044. https://doi.org/10.1016/j.soard.2015.11.019 CrossRefPubMed

27.

de Jong PE, Curhan GC (2006) Screening, monitoring, and treatment of albuminuria: public health perspectives. J Am Soc Nephrol 17:2120–2126. https://doi.org/10.1681/ASN.2006010097 CrossRefPubMed

28.

Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL, Robertson RP, Rubino F, Kahn R, Kirkman MS (2009) How do we define cure of diabetes? Diabetes Care 32:2133–2135. https://doi.org/10.2337/dc09-9036 CrossRefPubMedPubMedCentral

29.

Brethauer SA, Kim J, el Chaar M, Papasavas P, Eisenberg D, Rogers A, Ballem N, Kligman M, Kothari S, ASMBS Clinical Issues Committee (2015) Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis 11:489–506. https://doi.org/10.1016/j.soard.2015.02.003 CrossRefPubMed

30.

Aminian A, Brethauer SA, Andalib A, Punchai S, Mackey J, Rodriguez J, Rogula T, Kroh M, Schauer PR (2016) Can sleeve gastrectomy “cure” diabetes? Long-term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes. Ann Surg 264:674–681. https://doi.org/10.1097/SLA.0000000000001857 CrossRefPubMed

31.

Brethauer SA, Aminian A, Romero-Talamás H, Batayyah E, Mackey J, Kennedy L, Kashyap SR, Kirwan JP, Rogula T, Kroh M, Chand B, Schauer PR (2013) Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg 258:628–636. https://doi.org/10.1097/SLA.0b013e3182a5034b CrossRefPubMed

32.

Chernecky C, Berger B (2013) Creatinine—serum. In: Chernecky C, Berger B (eds) Laboratory tests and diagnostic procedures, 6th edn. Elsevier, St Louis, MO, pp 266–432

33.

Basi S, Fesler P, Mimran A, Lewis JB (2008) Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander? Diabetes Care 31(Suppl 2):S194–S201CrossRefPubMed

34.

Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH, Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators (2004) Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 110:2809–2816CrossRefPubMed

35.

Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y (2005) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 45:198–202CrossRefPubMed

36.

Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P, Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870–878CrossRefPubMed

37.

Zeve JL, de M, Tomaz, Nassif CAB, Lima PAN, Sansana JH, Zeve LRZ CH (2013) Obese patients with diabetes mellitus type 2 undergoing gastric bypass in Roux-en-Y: analysis of results and its influence in complications. Arq Bras Cir Dig 26(Suppl 1):47–52CrossRefPubMed

38.

Kota SK, Ugale S, Gupta N, Modi KD (2012) Laparoscopic ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes. Diabetes Metab Syndr Clin Res Rev 6:125–131. https://doi.org/10.1016/j.dsx.2012.09.014 CrossRef

39.

Amor A, Jiménez A, Moizé V, Ibarzabal A, Flores L, Lacy AM, Vidal J (2013) Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery. Surg Endosc 27:2046–2051. https://doi.org/10.1007/s00464-012-2708-3 CrossRefPubMed

40.

Zhang H, Di J, Yu H, Han X, Li K, Zhang P (2015) The short-term remission of diabetic nephropathy after Roux-en-Y gastric bypass in Chinese patients of T2DM with obesity. Obes Surg 25:1263–1270. https://doi.org/10.1007/s11695-015-1666-y CrossRefPubMedPubMedCentral

41.

Saliba J, Kasim NR, Tamboli RA, Isbell JM, Marks P, Feurer ID, Ikizler A, Abumrad NN (2010) Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery 147:282–287. https://doi.org/10.1016/j.surg.2009.09.017 CrossRefPubMed

42.

Miras AD, Chuah LL, Khalil N, Nicotra A, Vusirikala A, Baqai N, Graham C, Ravindra S, Lascaratos G, Oliver N, le Roux CW (2015) Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case–control study. Diabetologia 58:1443–1447. https://doi.org/10.1007/s00125-015-3595-7 CrossRefPubMedPubMedCentral

43.

Carlsson LMS, Romeo S, Jacobson P, Burza MA, Maglio C, Sjöholm K, Svensson P-A, Haraldsson B, Peltonen M, Sjöström L (2015) The incidence of albuminuria after bariatric surgery and usual care in swedish obese subjects (SOS): a prospective controlled intervention trial. Int J Obes 39:169–175. https://doi.org/10.1038/ijo.2014.72 CrossRef

44.

Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, UKPDS Study Group (2006) Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55:1832–1839. https://doi.org/10.2337/db05-1620 CrossRefPubMed

Titel: Long-term impact of bariatric surgery in diabetic nephropathy
verfasst von: LeAnne Young
Zubaidah Nor Hanipah
Stacy A. Brethauer
Philip R. Schauer
Ali Aminian
Publikationsdatum: 24.09.2018
Verlag: Springer US
Erschienen in: Surgical Endoscopy / Ausgabe 5/2019
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-018-6458-8

Neu im Fachgebiet Chirurgie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | HNO-Chirurgie | Nachrichten

HNO-Op. auch mit über 90?

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Long-term impact of bariatric surgery in diabetic nephropathy

Abstract

Background

Methods

Results

Conclusions

Neu im Fachgebiet Chirurgie

Hochrisiko-Eingriffe für postoperative Übelkeit

HNO-Op. auch mit über 90?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

Ileal interposition coupled with duodenal diverted sleeve gastrectomy versus standard medical treatment in type 2 diabetes mellitus obese patients: long-term results of a case–control study

Is hyperkinetic gallbladder an indication for cholecystectomy?

Effect of ilaprazole on the healing of endoscopic submucosal dissection-induced gastric ulcer: randomized-controlled, multicenter study

Quantitative analysis of colon perfusion pattern using indocyanine green (ICG) angiography in laparoscopic colorectal surgery

Intraoperative air leak test reduces the rate of postoperative anastomotic leak: analysis of 777 laparoscopic left-sided colon resections

A novel technique of pancreaticojejunostomy for laparoscopic pancreaticoduodenectomy

Neu im Fachgebiet Chirurgie

Hochrisiko-Eingriffe für postoperative Übelkeit

HNO-Op. auch mit über 90?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“